DRD5 Antikörper (C-Term)
Kurzübersicht für DRD5 Antikörper (C-Term) (ABIN2255768)
Target
Alle DRD5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Kreuzreaktivität
- Human, Maus, Ratte (Rattus)
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu Mo Rt
-
Produktmerkmale
- DRD5 (DRD1L2, DRD1B, D(5) dopamine receptor, Dopamine D5 receptor)
-
Aufreinigung
- Purified by immunoaffinity chromatography.
-
Immunogen
- A synthetic peptide corresponding to a sequence at the C-terminus of mouse DRD5, different from the related rat sequence by two amino acids, and from the related human sequence by three amino acids.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Reconstitution: Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
Buffer
- Supplied as a lyophilized powder. Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.
-
Konservierungsmittel
- Sodium azide, Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- 4°C/-20°C
-
-
- DRD5 (Dopamine Receptor D5 (DRD5))
-
Andere Bezeichnung
- DRD5
-
UniProt
- Q8BLD9
-
Pathways
- Regulation of Systemic Arterial Blood Pressure by Hormones, cAMP Metabolic Process, Regulation of long-term Neuronal Synaptic Plasticity
Target
-